NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/07/2022
Voltar para busca
Dado oficial do USPTO
EXCIVA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
66
Atualização mais recente
05/07/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
06/10/2016
Data de registro
05/07/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/07/2022
Última transação
05/07/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Primeiro uso
02/07/2018
Primeiro uso no comércio
02/07/2018
Código do desenho
4
Tipo de titular
16
Localização do titular
Vernon Hills, IL
Examinador
HARMON, RAYMOND E
Unidade examinadora
L30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
EXCIVA LLC
EXCIVA UG (haftungsbeschränkt)
EXCIVA UG (haftungsbeschränkt)
Representantes
SREENIVASARAO VEPACHEDU EXCIVA LLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctionhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for reducing sexual activity; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary system; for the treatment of inflammatory disorders; for use in dermatologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesfor the treatment of bacteria-based diseasesfor the treatment of diabetesanti - infective preparationsantiviral preparationsantibioticsantifungal preparations and vaccines; Pharmaceutical preparations for the prevention of disorders of the nervous system including central nervous system (CNS) and peripheral nervous system (PNS)peripheral nerve disordersmentalneurologicalpsychologicalpsychosomaticposttraumatic stressalcoholnicotinedrug dependence related diseasesdisorders and conditions; Pharmaceutical preparations for the treatment of disorders of the nervous system including central nervous system (CNS) and peripheral nervous system (PNS)peripheral nerve disordersmentalneurologicalpsychologicalpsychosomaticposttraumatic stressalcoholnicotinedrug dependence related diseasesdisorders and conditions; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of worms in pets; Pharmaceutical preparations for the treatment of disorders of the nervous system including central nervous system (CNS) and peripheral nervous system (PNS)peripheral nerve disordersmentalneurologicalpsychologicalpsychosomaticposttraumatic stressalcoholnicotinedrug dependence related diseasesdisorders and conditions; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorderssports related injuriesfor knee cartilage regeneration; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations of disorders of the nervous system including central nervous system (CNS) and peripheral nervous system (PNS)peripheral nerve disordersmentalneurologicalpsychologicalpsychosomaticposttraumatic stressalcoholnicotinedrug dependence related diseasesdisorders and conditions; Pharmaceutical preparationsa blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparationsa drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparationsa topical preparation for the treatment of ocular disorders prescribed by ophthalmologistseye surgeonsoptometrists; Pharmaceutical preparationsan analgesic for human consumption taken orally; Pharmaceutical preparationsanticoagulants; Pharmaceutical preparationsantidepressants; Pharmaceutical preparationsappetite suppressants; Pharmaceutical preparationsdantrolene sodium for injection; Pharmaceutical preparationselixirs for the treatment of disorders of the nervous system including central nervous system (CNS) and peripheral nervous system (PNS)peripheral nerve disordersmentalneurologicalpsychologicalpsychosomaticposttraumatic stressalcoholnicotinedrug dependence related diseasesdisorders and conditions; Pharmaceutical preparationsinjectable contraceptives; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticalsanti-infectives; Pharmaceuticalsantihelmintics; Pharmaceuticalsinducers of erections; Pharmaceuticalslipid lowering agents; Pharmaceuticalspsychotropics; Preparations for the suppression of hormones; Preparations for the treatment of asthma; Preparations for the treatment of burns; Preparations for treating colds; Preparations in the form of granules and liquids for controlling and removing moss; Preparations in the form of powders for controlling and removing moss; Preparations to destroy mildew; Preparations to prevent chewing or biting by animals; Preparations to prevent nail-biting and thumb-sucking; Prescription and non-prescription medicinespillstabletscapsulescapletsliquid dropssachets and pharmaceutical preparations for the treatment of cardiovascular disorders
Publicações
Histórico de despachos e eventos da marca no USPTO.
66 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
05/07/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/06/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/06/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/06/2022
ALIE
ASSIGNED TO LIE
28/05/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
25/05/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
15/02/2022
GNFR
FINAL REFUSAL E-MAILED
15/02/2022
CNFR
SU - FINAL REFUSAL - WRITTEN
15/02/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/01/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/01/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/01/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/10/2021
GNRT
NON-FINAL ACTION E-MAILED
07/10/2021
CNRT
SU - NON-FINAL ACTION - WRITTEN
07/10/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
14/09/2021
IURF
IU INFORMAL RESPONSE RECEIVED
31/08/2021
EISU
TEAS STATEMENT OF USE RECEIVED
31/08/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
31/08/2021
IUFF
USE AFFIDAVIT FAILED FORMALITIES
31/08/2021
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
28/08/2021
INCS
ITU OFFICE ACTION ISSUED FOR STATEMENT OF USE
28/08/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
28/08/2021
IUAF
USE AMENDMENT FILED
25/08/2021
EISU
TEAS STATEMENT OF USE RECEIVED
25/08/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/05/2021
TMBN
TTAB RELEASE CASE TO TRADEMARKS
29/03/2021
OP.T
OPPOSITION TERMINATED NO. 999999
29/03/2021
TTCD
BOARD DECISION COUNTERCLAIM DENIED
29/03/2021
DOCK
ASSIGNED TO EXAMINER
29/03/2021
OP.D
OPPOSITION DISMISSED NO. 999999
25/03/2021
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
29/07/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/07/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/07/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/07/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/07/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/07/2020
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
07/08/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/04/2018
OP.I
OPPOSITION INSTITUTED NO. 999999
17/01/2018
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
17/10/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/09/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/09/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/09/2017
PUBO
PUBLISHED FOR OPPOSITION
19/09/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
30/08/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/08/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/07/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/07/2017
ALIE
ASSIGNED TO LIE
18/07/2017
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/06/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/05/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/05/2017
GNFR
FINAL REFUSAL E-MAILED
01/05/2017
CNFR
FINAL REFUSAL WRITTEN
01/05/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/04/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/04/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/04/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
14/01/2017
GNRT
NON-FINAL ACTION E-MAILED
14/01/2017
CNRT
NON-FINAL ACTION WRITTEN
14/01/2017
DOCK
ASSIGNED TO EXAMINER
13/01/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/10/2016
NWAP
NEW APPLICATION ENTERED
10/10/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EXCIVA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.